Related by context. Frequent words. (Click for all words.) 82 GVAX R 81 oncolytic virus therapies 77 Initiates Phase II 75 Panzem R 74 Completes Patient Enrollment 73 refractory chronic lymphocytic 73 ® bortezomib 73 VEGFR2 inhibitor 73 R sorafenib tablets 72 TRAIL receptor antibodies 72 ZFP Therapeutics 72 trastuzumab DM1 T DM1 72 GRNVAC1 71 Daclizumab 71 Omacetaxine 71 Allovectin 7 71 Panzem R NCD 71 PSMA ADC 71 immunotherapeutic agent 71 Commences Phase 71 PEG SN# 70 Factor VIIa 70 liposomal formulation 70 Romidepsin 70 Presents Positive 70 BiTE R 70 ALN PCS 70 inflammatory autoimmune diseases 70 hepatitis C lupus 70 Darinaparsin 70 MVA BN R 70 forodesine 70 XL# XL# XL# XL# 70 MKC# 70 huC# DM4 69 sorafenib tablets 69 2 methoxyestradiol 69 Thiarabine 69 metastatic colorectal 69 Xanafide 69 www.vivus.com 69 Cotara R 69 KNS # 69 Tesetaxel 69 regarding Aethlon Medical 69 proteasome inhibitor 69 targeting CD# 68 AEG# 68 Tarvacin TM 68 PLK1 SNALP 68 catheter occlusion 68 based pretargeting methods 68 Initiate Phase 68 Meets Primary Endpoint 68 BiovaxID TM 68 BrachySil TM 68 lung pancreatic 68 Inc. Nasdaq INFI 68 candidate ridaforolimus 68 Phase Ib II 68 IMC #B 68 Genaera Corporation 67 CMV vaccine 67 cutaneous T 67 CCX# 67 candidates bavituximab 67 Emergent marketed 67 PRT# 67 developing Zerenex TM 67 R bortezomib 67 multi kinase inhibitor 67 drug conjugate 67 Proxinium TM 67 Pivotal Phase 67 HGS ETR2 67 Receives Orphan Drug Designation 67 pharma.com 67 Degarelix 67 Argatroban 67 vosaroxin 67 Metastatic Melanoma 67 Onconase 67 ThermoDox R 67 fluoroquinolone class 67 Pivotal Phase III 67 www.syntapharma.com 67 Kinase Inhibitor 67 personalized immunotherapy 67 tolevamer 67 Panzem 67 REGN# 67 Aplidin 67 fibrosis IPF 67 TELINTRA 67 Inc Therapeutic Competitors 67 Recombinant Human 67 Phase IIb clinical trials 66 HER1 66 Initiated Phase 66 immunotherapeutics 66 RhuDex ®